Home » Newsletters » BioWorld

BioWorld

Nov. 19, 1993

View Archived Issues

SDI1 GENE INHIBITS CELL GROWTH

SIGNS THAT EUROPE IS EMERGING FROM BIOTECH FREEZE

CELTRIX REPORTS ON BETAKINE

CHIRON RAISES $201M FROM SALE OF NOTES

ZYNAXIS SIGNS MARKETING PACT IN SPAIN

PERSEPTIVE BIOSYSTEMS SPINS OFF R&D COMPANY

CONTRACEPTIVE VACCINES ADVANCE TO PRIMATES

GTI COMPLETES FOLLOW-ON

STORAGE BANK ESTABLISHED FOR CORD BLOOD STEM CELLS

ARRIS COMPLETES 'SILENT' IPO

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.